ZKR Orthopedics Awarded IDE Approval for Clinical Trial

ZKR Orthopedics received Investigational Device Exemption (IDE) approval from FDA for a multicenter prospective clinical trial using the LIFT implant.

The PELICAN trial is designed as a prospective, propensity matched non-inferiority trial which will enroll approximately 245 patients at 24 sites in the U.S. and Europe. The treatment cohort...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us